Article
Cell facilitation promotes growth and survival under drug pressure in breast cancer
29 Jun 2023
Abstract excerpt
The interplay of positive and negative interactions between drug-sensitive and resistant cells influences the effectiveness of treatment in heterogeneous cancer cell populations. Here, we study interactions between estrogen receptor-positive breast cancer cell lineages that are sensitive and resistant to ribociclib-induced cyclin-dependent kinase 4 and 6 (CDK4/6) inhibition. In mono- and coculture, we find that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
